Organisation paid for research Program year 2025 Source: CMS Open Payments

North County Neurology Associates

Neither a doctor nor a teaching hospital

Research payments

$2,922,264

98 payments

Through program year 2025, North County Neurology Associates is reported as receiving $2,922,264 in research payments, across 98 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$14,577	7
2024	Research	$52,188	16
2023	Research	$1,010,414	28
2022	Research	$1,057,078	15
2021	Research	$673,449	11
2020	Research	$68,559	16
2019	Research	$45,998	5

Breakdown

Who paid Research payments · program years 2019–2025

Eli Lilly and Company $2,631,886 22 payments
AbbVie, Inc. $120,811 41 payments
LivaNova USA, Inc. $93,050 19 payments
H. Lundbeck A S $28,688 7 payments
Amgen Inc. $27,350 2 payments
Argenx US, Inc. $17,080 5 payments
Ucb SA $3,398 2 payments

Studies the money was for Research payments · program years 2019–2025

Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimers Disease $1,483,743 6 payments
A Study of Donanemab (Ly3002813) in Participants With Early Alzheimer's Disease (Trailblazer-Alz 2) $512,560 2 payments
Assessment of Safety Tolerability and Efficacy Measured By Amyloid Reduction of Ly3372993 in Early Symptomatic Alzheimer's Disease $428,180 2 payments
Assessment of Safety, Tolerability, and Efficacy Measured By Amyloid Reduction of Ly3372993 in Early Symptomatic Alzheimer's Disease $194,416 4 payments
(OSPREY)Treating Obstructive Sleep APnea using TaRgetEd HYpoglossal Neurostimulation $58,750 10 payments
M18-918 $35,981 9 payments
(THN3)Targeted Hypoglossal Neurostimulation Study #3 $34,300 9 payments
Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine $29,605 18 payments
A Parallel Group, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Subjects Experiencing An Acute Attack of Migraine $28,688 7 payments
Center-Based Chart Review for Migraine Patients $27,350 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.